ATE245141T1 - Benzolsulfonamidderivate - Google Patents

Benzolsulfonamidderivate

Info

Publication number
ATE245141T1
ATE245141T1 AT98303797T AT98303797T ATE245141T1 AT E245141 T1 ATE245141 T1 AT E245141T1 AT 98303797 T AT98303797 T AT 98303797T AT 98303797 T AT98303797 T AT 98303797T AT E245141 T1 ATE245141 T1 AT E245141T1
Authority
AT
Austria
Prior art keywords
alkyl
receptor
vinylene
trifluoromethyl
chem
Prior art date
Application number
AT98303797T
Other languages
English (en)
Inventor
Shuichi Ohuchida
Yuuki Nagao
Takayuki Maruyama
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of ATE245141T1 publication Critical patent/ATE245141T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT98303797T 1997-05-15 1998-05-14 Benzolsulfonamidderivate ATE245141T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14095997 1997-05-15

Publications (1)

Publication Number Publication Date
ATE245141T1 true ATE245141T1 (de) 2003-08-15

Family

ID=15280803

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98303797T ATE245141T1 (de) 1997-05-15 1998-05-14 Benzolsulfonamidderivate

Country Status (14)

Country Link
US (1) US6235777B1 (de)
EP (1) EP0878465B1 (de)
KR (1) KR19980087031A (de)
CN (1) CN1201786A (de)
AT (1) ATE245141T1 (de)
AU (1) AU6600898A (de)
CA (1) CA2237709A1 (de)
DE (1) DE69816367T2 (de)
DK (1) DK0878465T3 (de)
ES (1) ES2203892T3 (de)
HU (1) HUP9801089A3 (de)
NO (1) NO982205L (de)
PT (1) PT878465E (de)
ZA (1) ZA984040B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1201238A4 (de) * 1999-07-29 2003-01-15 Ono Pharmaceutical Co Sulfonamidderivate und heilmittel für allodynie
GB9930082D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
SE0100873D0 (sv) * 2001-03-13 2001-03-13 Astrazeneca Ab Method of treatment
EP1369129A4 (de) * 2001-03-14 2005-08-03 Ono Pharmaceutical Co Heilmittel gegen depression mit einem ep1 antagonist als wirkstoff
WO2003043655A1 (fr) * 2001-11-19 2003-05-30 Ono Pharmaceutical Co., Ltd. Remedes pour la frequence urinaire
GB0317500D0 (en) * 2003-07-25 2003-08-27 Pfizer Ltd Treatment of bph
MX2007004526A (es) * 2004-10-12 2007-09-21 Decode Genetics Inc Arilsulfonamidas biciclicas peri-sustituidas para la enfermedad arterial oclusiva.
KR20070091607A (ko) * 2004-10-12 2007-09-11 디코드 제네틱스, 아이엔씨. 폐쇄성 동맥 질환용의 설폰아미드 주변 치환된바이사이클릭 화합물
US7714017B2 (en) * 2004-10-12 2010-05-11 Decode Genetics, Ehf Carboxylic acid peri-substituted bicyclics for occlusive artery disease
WO2007137042A2 (en) * 2006-05-16 2007-11-29 Decode Genetics, Ehf. Process for preparing 7- (acryl0yl) -ind0les
TW200817319A (en) * 2006-08-10 2008-04-16 Astellas Pharma Inc Sulfonamide compound or salt thereof
ES2437323T3 (es) 2007-02-16 2014-01-10 Ono Pharmaceutical Co., Ltd. Agente terapéutico para trastornos de la micción
WO2014015247A1 (en) 2012-07-19 2014-01-23 Cayman Chemical Company, Inc. Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions
US9676712B2 (en) 2013-03-15 2017-06-13 Cayman Chemical Company, Inc. Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
AU2014290512A1 (en) 2013-07-19 2015-11-12 Cayman Chemical Company, Inc. Methods, systems, and compositions for promoting bone growth

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1278577C (en) 1985-11-18 1991-01-02 Tatsuo Tsuri Bicyclic sulfonamide derivatives
EP0312906A3 (de) * 1987-10-23 1990-09-05 Ono Pharmaceutical Co., Ltd. Sulfonamidderivate
JP2565746B2 (ja) * 1987-10-23 1996-12-18 小野薬品工業株式会社 新規な炭素環系スルホンアミド誘導体
CA2113787A1 (en) 1993-01-29 1994-07-30 Nobuyuki Hamanaka Carbocyclic sulfonamides

Also Published As

Publication number Publication date
DK0878465T3 (da) 2003-11-03
EP0878465A2 (de) 1998-11-18
DE69816367T2 (de) 2004-04-15
DE69816367D1 (de) 2003-08-21
HUP9801089A3 (en) 2001-08-28
HUP9801089A2 (hu) 1999-11-29
ES2203892T3 (es) 2004-04-16
PT878465E (pt) 2003-12-31
AU6600898A (en) 1998-11-19
CN1201786A (zh) 1998-12-16
KR19980087031A (ko) 1998-12-05
NO982205L (no) 1998-11-16
EP0878465A3 (de) 2001-03-14
NO982205D0 (no) 1998-05-14
EP0878465B1 (de) 2003-07-16
US6235777B1 (en) 2001-05-22
HU9801089D0 (en) 1998-07-28
ZA984040B (en) 1998-11-20
CA2237709A1 (en) 1998-11-15

Similar Documents

Publication Publication Date Title
ATE245141T1 (de) Benzolsulfonamidderivate
ZA986801B (en) Chemical compound.
ATE210650T1 (de) Sulfonamid substituierte benzopyrane als kaliumkanalaktivatoren
NO20003111L (no) Orto-antranilamidderivater som antikoagulanter
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
KR970704864A (ko) 세정제 조성물
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
ATE263771T1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
BR9810163A (pt) Compostos ou suas composições
CA2221110A1 (en) Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
UY24010A1 (es) Nuevos pirrolocarbazoles
NO995590D0 (no) 20-Aryl-5<alfa>-pregnan-derivater
IS5497A (is) Bífenýlamidínafleiður
ATE280767T1 (de) Antidiabetische thiazolidindione und ihre herstellung
FI870090A0 (fi) Laongkedjade alkylresorcinolfosfiter.
CA2393175A1 (en) Bridged metallocene compounds as olefin-polymerization catalysts
NO983133L (no) Flytforbedrende middel for mineraloljer
BR0002516A (pt) Compostos úteis em terapia
BR0007897A (pt) Uso de derivados anticonvulsivantes para otratamento de bulimia nervosa
ATE105565T1 (de) Pradimicinderivate.
MX9601953A (es) Nuevo compesto derivados de 5h-tiazolo [3,2-a] pirimidin-5-ona.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0878465

Country of ref document: EP

REN Ceased due to non-payment of the annual fee